Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis
出版年份 2018 全文链接
标题
Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-03-29
DOI
10.1038/s41598-018-23569-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
- (2017) Atli Thorarensen et al. JOURNAL OF MEDICINAL CHEMISTRY
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
- (2016) Jean-Baptiste Telliez et al. ACS Chemical Biology
- Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling
- (2016) Geoffrey A Smith et al. Nature Chemical Biology
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Development of Selective Covalent Janus Kinase 3 Inhibitors
- (2015) Li Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol
- (2015) Eric R. Goedken et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tofacitinib
- (2014) Deepti Vyas et al. ANNALS OF PHARMACOTHERAPY
- Selective inhibitors of the Janus kinase Jak3—Are they effective?
- (2014) Gebhard Thoma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors
- (2014) Mark E. McDonnell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors
- (2014) Mark E. Flanagan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
- (2013) Qingsong Liu et al. CHEMISTRY & BIOLOGY
- The Role of JAK-3 in Regulating TLR-Mediated Inflammatory Cytokine Production in Innate Immune Cells
- (2013) H. Wang et al. JOURNAL OF IMMUNOLOGY
- Discovery and Optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as Novel Selective and Orally Bioavailable Discoidin Domain Receptor 1 (DDR1) Inhibitors
- (2013) Mingshan Gao et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models
- (2012) Michael Soth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
- (2012) Tjeerd Barf et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice
- (2010) Tsung H. Lin et al. ARTHRITIS AND RHEUMATISM
- Identification of a Potent Janus Kinase 3 Inhibitor with High Selectivity within the Janus Kinase Family
- (2010) Gebhard Thoma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
- (2009) Neal K. Williams et al. JOURNAL OF MOLECULAR BIOLOGY
- Tyrosine kinases as targets for the treatment of rheumatoid arthritis
- (2009) Christina D'Aura Swanson et al. Nature Reviews Rheumatology
- Tyrosine kinases as targets in rheumatoid arthritis
- (2008) Antonio G. Tristano INTERNATIONAL IMMUNOPHARMACOLOGY
- Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)
- (2008) Jian-kang Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis
- (2008) Anthony J Milici et al. ARTHRITIS RESEARCH & THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started